Shiny Health & Wellness Corp. announced that it has received CAD 0.225 million in funding
On the same date, the company announced that it has issued 2,250,000 units at an issue price of CAD 0.10 for the gross proceeds of CAD 225,000 in the first tranche. There is no finders fee to be paid on this first tranche. Closing of the First tranche of the Offering is subject to receipt of all necessary regulatory approvals including acceptance of the TSX Venture Exchange.
On November 6, 2023, the company announced that it has received approval from TSX Venture Exchange. The transaction is expected to close on December 1, 2023. The unit shares, warrant shares and any common shares of the company that are issuable from any finder's warrants will be subject to a hold period of four months and one day following the closing date of the offering in accordance with applicable securities laws.
On December 6, 2023, the company announced that it has received approval from the TSX Venture Exchange to extend the closing of its previously announced non-brokered private placement to January 4, 2024. It anticipates that the second and final tranche closing will occur on or before January 4, 2024. The closing of the Offering is subject to receipt of all necessary regulatory approvals including the TSX Venture Exchange. Finder's fees will be payable in accordance with the policies of the TSXV. The Unit Shares, Warrant Shares and any common shares of the Company that are issuable from any finder's warrants will be subject to a hold period of four months and one day following the closing date of the Offering in accordance with applicable securities laws.
On January 4, 2024, the company announced that it does not anticipate any more proceeds from this offering and has closed the transaction in its first tranche. No Finder's fees will be paid in the transaction. The transaction included participation from one placee.